Park Ha Biological Technology Co., Ltd. (PHH)
NASDAQ: PHH · Real-Time Price · USD
0.4119
-0.0121 (-2.85%)
At close: Oct 14, 2025, 4:00 PM EDT
0.4239
+0.0120 (2.91%)
After-hours: Oct 14, 2025, 7:48 PM EDT
Company Description
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People’s Republic of China.
The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand.
It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People’s Republic of China.
Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.
Park Ha Biological Technology Co., Ltd.
| Country | China |
| Founded | 2016 |
| IPO Date | Dec 27, 2024 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| Employees | 17 |
| CEO | Xiaoqiu Zhang |
Contact Details
Address: 901 & 901-2, Building C Wuxi, 214000 China | |
| Phone | 86 40 0012 7562 |
| Website | parkha.cn |
Stock Details
| Ticker Symbol | PHH |
| Exchange | NASDAQ |
| Fiscal Year | November - October |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001986247 |
| CUSIP Number | 693320103 |
| ISIN Number | US6933202029 |
| SIC Code | 2840 |
Key Executives
| Name | Position |
|---|---|
| Xiaoqiu Zhang | Chief Executive Officer and Chairman of the Board |
| Xiaoyan Zhu | Chief Financial Officer |
| Xinyu Li | Chief Technology Officer and Product Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 8, 2025 | 6-K | Report of foreign issuer |
| Sep 25, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Sep 19, 2025 | F-1 | Registration statement for certain foreign private issuers |
| Sep 18, 2025 | 6-K | Report of foreign issuer |
| Sep 5, 2025 | 6-K | Report of foreign issuer |
| Sep 5, 2025 | DRS | [Cover] Draft Registration Statement |
| Aug 26, 2025 | 6-K | Report of foreign issuer |
| Aug 25, 2025 | 6-K | Report of foreign issuer |
| Jul 10, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 3, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |